New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq ・ Market Cap: Small
CEO Purchases
Abnormal High-Volume Purchases
Top Executive Recent Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 7 / 15 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 4 / 11 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 1,912,000 / 3,860,571 273,143 / 257,371 |
| VALUE PURCHASED/SOLD Transaction Average | $2,051,150 / $10,040,515 $293,021 / $669,368 |
| PURCHASE RANGE | $2,800 - $1,560,000 |
| SALE RANGE | $2,718.86 - $3,807,101.52 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
2 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
1 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
21.55%
DIRECTORS
0%
OFFICERS
78.45%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.605 0.2 |
VALUE GINI INDEX Sector Average | 0.615 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
0%
DIRECTORS
0.5%
OFFICERS
99.5%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.664 0.295 |
VALUE GINI INDEX Sector Average | 0.871 0.288 |
AN2 Therapeutics, Inc. 1Y Trade Transactions
Submission Date Period of Report | Insider | Position | Total Value | Shares | Share Price | Ownership % Change | Shares Owned | Post Day Stock Change | Post Week Stock Change | |
|---|---|---|---|---|---|---|---|---|---|---|
2025-01-07 2025-01-03 | Day Lucy | Officer | -$3,962 | 2,957 | $1.34 | -8.3% | 32,670 | N/A | N/A | |
2025-01-07 2025-01-03 | Chanda Sanjay | Officer | -$3,962 | 2,957 | $1.34 | -9.02% | 29,824 | N/A | N/A | |
2025-01-07 2025-01-03 | Prior Stephen David | Officer | -$2,719 | 2,029 | $1.34 | -5.74% | 33,313 | N/A | N/A | |
2025-01-07 2025-01-03 | Eizen Joshua M | Officer | -$12,948 | 9,663 | $1.34 | -7.65% | 116,672 | N/A | N/A | |
2024-12-10 2024-12-06 | Readnour Robin Shane | Director | +$87,600 | 60,000 | $1.46 | +10.13% | 652,573 | N/A | N/A | |
2024-11-27 2024-11-26 | Readnour Robin Shane | Director | +$105,750 | 75,000 | $1.41 | +13.7% | 622,573 | +16.79% | +9.49% | |
2024-11-27 2024-11-27 | Zakrzewski Joseph S | Director | +$2,800 | 2,000 | $1.4 | +0.38% | 531,079 | +16.79% | +9.49% | |
2024-11-21 2024-11-19 | Readnour Robin Shane | Director | +$220,000 | 200,000 | $1.1 | +63.53% | 514,788 | +8.94% | +30.08% | |
2024-11-20 2024-11-18 | Zakrzewski Joseph S | Director | +$25,000 | 25,000 | $1 | +4.96% | 529,079 | -5.38% | +5.38% | |
2024-11-18 2024-11-18 | Easom Eric | Director | +$50,000 | 50,000 | $1 | +3.81% | 1,361,012 | +30.00% | +39.00% |